ConductScience.org, home

Paper3992249

Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.

Mash DC and 2 others. Science, 1985. Cited by 647 papers, by iCite.

Cite this record

ConductScience Library. Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Papers, record 3992249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3992249

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.
PubMed
Journal
Science
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
647
iCite
Relative citation ratio, by iCite
23.1
iCite
Revised in PubMed
2022-03-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mash DCD C
2Flynn DDD D
3Potter LTL T

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Cerebral CortexMajor topic
Choline O-AcetyltransferaseMajor topic
Receptors, MuscarinicMajor topic
Synaptic MembranesMajor topic
Aged
Animals
Cholinergic Fibers
Denervation
Humans
Male
Oxotremorine
Quinuclidinyl Benzilate
Rats
Rats, Inbred Strains

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
HLO-7188NHLBI NIH HHSUnited StatesPubMedPubMed
T32HL007188NIHNIH RePORTER

Download CSV of grants

Cited by102

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 647 citations.

PMIDTitleJournalYearIn PapersSource
42614314Emerging neuroprotective mechanisms and therapeutic potential of natural polysaccharides in Alzheimer's disease.Front Aging Neurosci2026https://conductscience.org/library/papers/42614314PubMed
41990387Path Integration in Alzheimer's Disease: Orientation, Movement, and Theta Rhythmicity.Annu Rev Neurosci2026https://conductscience.org/library/papers/41990387PubMed
40495777Combined Effects of Intermittent Hypoxia and Amyloid Beta on Hippocampal Activity, Its Cholinergic Modulation, and Memory.Hippocampus2025https://conductscience.org/library/papers/40495777PubMed
40237061Photodynamic and Photothermal Therapies using Nanotechnology Approach in Alzheimer's Disease.Curr Neuropharmacol2025https://conductscience.org/library/papers/40237061PubMed
40133398Agarwood leaf ethanol extract provides neuroprotective properties and promotes cholinergic differentiation of HT22 hippocampal neurons.Sci Rep2025https://conductscience.org/library/papers/40133398PubMed
39039673Advances in Understanding and Managing Alzheimer's Disease: From Pathophysiology to Innovative Therapeutic Strategies.Curr Drug Targets2024https://conductscience.org/library/papers/39039673PubMed
38578893Frontal Cortex Lipid Alterations During the Onset of Alzheimer's Disease.J Alzheimers Dis2024https://conductscience.org/library/papers/38578893PubMed
34450027Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations.Cell2021https://conductscience.org/library/papers/34450027PubMed
34272732Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance.J Neurochem2021https://conductscience.org/library/papers/34272732PubMed
34164794Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects.Drugs R D2021https://conductscience.org/library/papers/34164794PubMed
34037379Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's Disease.ACS Chem Neurosci2021https://conductscience.org/library/papers/34037379PubMed
33931975Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies.Clin Transl Med2021https://conductscience.org/library/papers/33931975PubMed
33891333Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M1 -acetylcholine receptor agonist: A randomized cross-over trial.Br J Clin Pharmacol2021https://conductscience.org/library/papers/33891333PubMed
33790746Neuromodulation of Persistent Activity and Working Memory Circuitry in Primate Prefrontal Cortex by Muscarinic Receptors.Front Neural Circuits2021https://conductscience.org/library/papers/33790746PubMed
33627325The Property-Based Practical Applications and Solutions of Genetically Encoded Acetylcholine and Monoamine Sensors.J Neurosci2021https://conductscience.org/library/papers/33627325PubMed
33351971First-in-man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M1 -receptor partial agonist for the treatment of dementias.Br J Clin Pharmacol2021https://conductscience.org/library/papers/33351971PubMed
33342413Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors.Curr Neuropharmacol2021https://conductscience.org/library/papers/33342413PubMed
33277628Genetically encoded sensors enable micro- and nano-scopic decoding of transmission in healthy and diseased brains.Mol Psychiatry2021https://conductscience.org/library/papers/33277628PubMed
32766549M1 muscarinic acetylcholine receptor dysfunction in moderate Alzheimer's disease pathology.Brain Commun2020https://conductscience.org/library/papers/32766549PubMed
32396366Nanoscopic Visualization of Restricted Nonvolume Cholinergic and Monoaminergic Transmission with Genetically Encoded Sensors.Nano Lett2020https://conductscience.org/library/papers/32396366PubMed

See all 102 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CHAT1103PubTator's text mininghttps://conductscience.org/library/genes/1103

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3992249

GET https://conductscience.org/api/papers/v1/3992249/cited_by?page=2